Free Trial

BridgeBio Pharma (BBIO) Institutional Ownership

BridgeBio Pharma logo
$65.48 +1.60 (+2.50%)
Closing price 04:00 PM Eastern
Extended Trading
$65.00 -0.48 (-0.73%)
As of 05:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for BridgeBio Pharma (NASDAQ:BBIO)

Current
Institutional Ownership
Percentage
99.85%
Number of
Institutional Buyers
(last 12 months)
257
Total
Institutional Inflows
(last 12 months)
$2.37B
Number of
Institutional Sellers
(last 12 months)
135
Total
Institutional Outflows
(last 12 months)
$2.78B
Get BBIO Insider Trade Alerts

Want to know when executives and insiders are buying or selling BridgeBio Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

BBIO Institutional Buying and Selling by Quarter

BridgeBio Pharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
6/3/2026 Parallel Advisors LLC894$66K0.0%+552.6%0.000%
5/28/2026 Avidity Partners Management LP10,000$711K0.1%N/A0.005%
5/26/2026 Glenmede Trust Co. NA13,656$1.01M0.0%-35.5%0.007%
5/19/2026 Janus Henderson Group PLC13,179,013$978.61M0.5%+19.8%6.729%
5/18/2026 California State Teachers Retirement System165,703$12.31M0.0%+23.7%0.085%
5/18/2026 Rock Springs Capital Management LP128,250$9.52M0.6%+23.9%0.065%
5/18/2026 Eagle Health Investments LP267,031$19.83M3.5%+3.0%0.136%
5/18/2026 Exome Asset Management LLC67,492$5.01M2.6%-16.4%0.034%
5/16/2026 The Manufacturers Life Insurance Company 1,977,080$146.82M0.1%+0.1%1.009%
5/16/2026 Quantinno Capital Management LP32,240$2.39M0.0%+199.2%0.016%
5/16/2026 SummitTX Capital L.P.31,253$2.32M0.1%-12.7%0.016%
5/16/2026 Castleark Management LLC81,737$6.07M0.2%-28.3%0.042%
5/16/2026 ABS Direct Equity Fund LLC1,243$86K0.1%N/A0.001%
5/15/2026 Granahan Investment Management LLC102,911$7.64M0.4%+1.1%0.053%
5/15/2026 Affinity Asset Advisors LLC150,000$11.14M0.6%-53.1%0.077%
5/14/2026 Renaissance Technologies LLC365,772$27.16M0.0%N/A0.187%
5/14/2026 Atika Capital Management LLC35,200$2.61M0.3%N/A0.018%
5/14/2026 Inceptionr LLC8,804$654K0.2%+46.9%0.004%
5/14/2026 Knott David M Jr90,000$6.68M3.9%+5.9%0.046%
5/14/2026 Mizuho Markets Americas LLC171,288$12.72M0.3%+5.9%0.087%
5/14/2026 Monashee Investment Management LLC67,139$4.99M2.7%-32.9%0.034%
5/13/2026 Cetera Investment Advisers61,733$4.58M0.0%-15.1%0.032%
5/13/2026 First Trust Advisors LP339,907$25.24M0.0%+20.7%0.174%
5/7/2026 WCM Investment Management LLC167,983$11.65M0.0%-3.8%0.086%
5/7/2026 Dimensional Fund Advisors LP561,945$41.68M0.0%+46.9%0.287%
5/7/2026 Parallel Advisors LLC894$66K0.0%+552.6%0.000%
5/7/2026 KBC Group NV4,743$352K0.0%+13.1%0.002%
5/7/2026 SEB Asset Management AB235,813$17.51M0.1%N/A0.120%
5/7/2026 Swiss National Bank286,000$21.24M0.0%+1.2%0.146%
5/7/2026 ANB Bank2,840$211K0.1%N/A0.001%
5/6/2026 California Public Employees Retirement System253,479$18.82M0.0%+21.9%0.129%
5/6/2026 Assetmark Inc.20,790$1.54M0.0%+423.7%0.011%
5/6/2026 Financiere des Professionnels Fonds d investissement inc.7,900$587K0.0%N/A0.004%
5/6/2026 Allspring Global Investments Holdings LLC889,356$66.21M0.1%-10.5%0.454%
5/6/2026 W.G. Shaheen & Associates DBA Whitney & Co5,050$375K0.0%-59.1%0.003%
5/5/2026 Hillsdale Investment Management Inc.167,742$12.46M0.3%+1.9%0.086%
5/4/2026 Emerald Mutual Fund Advisers Trust320,211$23.78M1.2%+1.1%0.164%
5/4/2026 Emerald Advisers LLC515,361$38.27M1.2%-3.8%0.263%
5/4/2026 Principal Financial Group Inc.1,330,415$98.80M0.1%+1.2%0.679%
5/4/2026 Teachers Retirement System of The State of Kentucky30,343$2.25M0.0%+7.6%0.015%
The REAL Reason Trump is Invading Iran (Ad)

For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel

Click here to find out what it is.
5/1/2026 Citizens Financial Group Inc. RI4,082$303K0.0%N/A0.002%
5/1/2026 Fifth Third Bancorp49,729$3.69M0.0%N/A0.025%
4/30/2026 Hsbc Holdings PLC32,708$2.43M0.0%+139.4%0.017%
4/30/2026 Sumitomo Mitsui Trust Group Inc.3,080$229K0.0%N/A0.002%
4/28/2026 Abel Hall LLC5,086$378K0.1%-51.9%0.003%
4/28/2026 QRG Capital Management Inc.7,174$533K0.0%+8.5%0.004%
4/27/2026 PFG Investments LLC7,725$574K0.0%+41.7%0.004%
4/27/2026 Leonteq Securities AG2,024$150K0.0%-22.0%0.001%
4/27/2026 Elevation Point Wealth Partners LLC3,271$243K0.0%N/A0.002%
4/25/2026 Strs Ohio23,700$1.76M0.0%+11.8%0.012%
4/22/2026 Janney Montgomery Scott LLC26,143$1.94M0.0%+2.1%0.013%
4/22/2026 Diamant Asset Management Inc.527,246$39.15M0.1%N/A0.272%
4/22/2026 Pictet Asset Management Holding SA1,381,184$101.50M0.1%+8.7%0.712%
4/20/2026 Assenagon Asset Management S.A.44,092$3.27M0.0%+31.6%0.023%
4/17/2026 Total Clarity Wealth Management Inc.13,682$1.02M0.2%+133.4%0.007%
4/16/2026 Diversified Trust Co43,971$3.27M0.1%+12.2%0.023%
3/20/2026 Hsbc Holdings PLC13,665$1.05M0.0%N/A0.007%
3/17/2026 Rockefeller Capital Management L.P.38,429$2.94M0.0%+189.8%0.020%
3/9/2026 Corient Private Wealth LLC16,436$1.26M0.0%-4.7%0.008%
2/19/2026 Compound Planning Inc.2,723$208K0.0%-82.1%0.001%
2/19/2026 Invesco Ltd.4,831,305$369.55M0.1%+23.0%2.507%
2/19/2026 Corient Private Wealth LLC16,436$1.26M0.0%-4.7%0.009%
2/18/2026 Mackenzie Financial Corp54,495$4.11M0.0%+8.9%0.028%
2/18/2026 ADAR1 Capital Management LLC213,414$16.32M1.2%-36.9%0.111%
2/18/2026 XTX Topco Ltd13,169$1.01M0.0%+162.4%0.007%
2/18/2026 VARCOV Co.4,447$340K0.1%N/A0.002%
2/18/2026 Voloridge Investment Management LLC638,883$48.87M0.2%+377.4%0.332%
2/18/2026 Virtus Investment Advisers LLC9,093$696K0.2%-18.9%0.005%
2/18/2026 Wellington Management Group LLP2,348,731$179.65M0.1%+130.4%1.219%
2/18/2026 SummitTX Capital L.P.35,785$2.74M0.1%-3.8%0.019%
2/18/2026 Sphera Funds Management LTD.107,746$8.24M1.6%-36.9%0.056%
2/18/2026 Odyssean LLC10,027$767K0.6%N/A0.005%
2/18/2026 Opaleye Management Inc.18,319$1.40M0.2%N/A0.010%
2/18/2026 Man Group plc20,004$1.53M0.0%-98.5%0.010%
2/18/2026 Ishara Investments LP36,000$2.75M3.2%N/A0.019%
2/18/2026 Janus Henderson Group PLC11,000,457$841.35M0.4%+25.8%5.708%
2/18/2026 Engineers Gate Manager LP15,574$1.19M0.0%+127.6%0.008%
2/18/2026 Cinctive Capital Management LP70,175$5.37M0.3%-26.7%0.036%
2/18/2026 Cormorant Asset Management LP1,200,000$91.79M4.2%-14.3%0.623%
2/18/2026 Boone Capital Management LLC184,963$14.15M4.7%-59.8%0.096%
2/17/2026 Freestone Grove Partners LP125,201$9.58M0.1%+33.9%0.065%
2/17/2026 Guggenheim Capital LLC34,734$2.66M0.0%-13.1%0.018%
2/17/2026 Viking Global Investors LP14,393,934$1.10B2.9%-9.9%7.469%
2/17/2026 ADAR1 Capital Management LLC213,414$16.32M1.2%-36.9%0.111%
2/17/2026 AQR Capital Management LLC134,517$10.29M0.0%+36.1%0.070%
2/17/2026 Abel Hall LLC10,571$809K0.2%N/A0.005%
2/17/2026 EFG International AG88,255$6.75M0.1%N/A0.046%
2/17/2026 Cetera Investment Advisers72,737$5.56M0.0%-2.7%0.038%
2/17/2026 Kovack Advisors Inc.10,300$788K0.0%N/A0.005%
2/17/2026 Farallon Capital Management LLC8,998,463$688.29M3.2%+9.8%4.669%
The 1934 playbook (Ad)

In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it coming — but those who did walked away wealthy.Trump holds that same legal authority today. Advisors close to the administration believe he may use it.If he does, the transfer moves fast. The window to position yourself on the right side is already closing.tc pixel

2/17/2026 Price T Rowe Associates Inc. MD3,828,746$292.86M0.0%+144.2%1.987%
2/17/2026 Rock Springs Capital Management LP103,500$7.92M0.4%+21.8%0.054%
2/17/2026 GeoWealth Management LLC6,299$482K0.0%-67.2%0.003%
2/17/2026 Osaic Holdings Inc.252,145$19.29M0.0%-3.0%0.131%
2/17/2026 Adage Capital Partners GP L.L.C.508,134$38.87M0.1%-46.2%0.264%
2/17/2026 Granahan Investment Management LLC101,805$7.79M0.3%-36.9%0.053%
2/17/2026 Kemnay Advisory Services Inc.539$41K0.0%N/A0.000%
2/17/2026 Captrust Financial Advisors3,714$284K0.0%N/A0.002%
2/17/2026 Summit Partners Public Asset Management LLC813,794$62.25M1.3%+0.9%0.422%
2/17/2026 Artisan Partners Limited Partnership279,067$21.35M0.0%-15.8%0.145%


BBIO Institutional Ownership - Frequently Asked Questions

During the previous two years, 380 institutional investors and hedge funds held shares of BridgeBio Pharma. The most heavily invested institutionals were Vanguard Group Inc. ($1.29B), Viking Global Investors LP ($1.10B), Janus Henderson Group PLC ($978.61M), Farallon Capital Management LLC ($688.29M), Invesco Ltd. ($369.55M), Geode Capital Management LLC ($344.69M), and Aisling Capital Management LP ($316.29M).Learn more on BridgeBio Pharma's institutional investors.

99.85% of BridgeBio Pharma's stock is owned by institutional investors. Learn more on BBIO's institutional investor holdings.

Of the 333 institutional investors that purchased BridgeBio Pharma's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Janus Henderson Group PLC ($5.03M), Norges Bank ($4.55M), Invesco Ltd. ($3.94M), Farallon Capital Management LLC ($3.55M), Brooklands Fund Management Ltd ($2.75M), Price T Rowe Associates Inc. MD ($2.62M), and Wellington Management Group LLP ($2.29M).

Institutional investors have bought a total of 36,613,914 shares in the last 24 months. This purchase volume represents approximately $2.37B in transactions.

Of the 135 institutional investors that sold BridgeBio Pharma's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: BNP Paribas Financial Markets ($27.38M), Viking Global Investors LP ($7.66M), HighTower Advisors LLC ($4.15M), Capital Research Global Investors ($2.06M), Woodline Partners LP ($1.51M), Man Group plc ($1.34M), and Assenagon Asset Management S.A. ($1.09M).

Institutional investors have sold a total of 55,673,492 shares in the last 24 months. This volume of shares sold represents approximately $2.78B in transactions.



This page (NASDAQ:BBIO) was last updated on 6/3/2026 by MarketBeat.com Staff.
From Our Partners